MSB - Most exciting 6 months, page-399

What do you think it will be, if the ARDS news is the first clinically successful news we get. Lets say placebo death rate 40%, MSB death rate 10% - so reduces your chances of death by 75%.

Lets say phase 3 is stopped next month - and it's immediately approved and advertised by FDA and Trump as the only approved treatment in the USA for ARDs - which it may well be as so far there are none.

What price do you pick for the stock. How many mum and dad investors are going to want in, how many funds are going to see the massive potential that was never factored in. How many people that saw the potential of Facebook / Google / Amazon etc are going to take note and jump onboard for the ride.

There isn't a precedence I can think of to compare with that would do the figure justice. So far - most Pharmas involved in the vaccines are up 300 - 500% since Jan 20, either still without a product or without conclusive phase 3 readouts.

Biotron went from 2 cents to 29 cents in a month in 2018 for a partial cure result for HIV - in a phase 2 trial...... up 1450%

There's Aquinox Pharmaceuticals, who moved up nearly 27,700% in Aug 2015 due to big Pharma trying to move in.... a 277 Bagger in less than 1 week.

And for us luckily we are listed on the NASDAQ which has companies that are massively overvalued, some of which are making 1 - 1.5 Billion profit a quarter, valued over a trillion dollars.

We are in unprecedented times and the whole world is suffering. I think if Ryoncil does what it says it does, we may all be very surprised, particularly if NASDAQ starts to lead - how else do big Pharma get a slice of the cherry!

As has been mentioned before, non of the analysts are seriously factoring in the PR benefit or the business opportunity for Covid.